Multiple Sclerosis, Depression, Sleep, Stress Psychological
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Having diagnosis of MS for at least 6 months, having been diagnosed with relapsing-remitting MS; They are receiving treatment with an immunomodulator; have Expanded Disability Status Scale (EDSS) less than or equal to 5.0; Aged between 18 and 65; have not had any outbreaks during the 3 month period prior to inclusion in the study; Media have at home (CD, MP3).
Exclusion criteria
Exclusion criteria: Being hospitalized at the time of data collection or outbreak at the time of data collection; have physical and / or mental changes that prevent the collection of data, such as motor or cognitive deficits; Continuous use of psychotropic medications (eg, antidepressants, benzodiazepines, antipsychotics or other stimulants); make use of complementary health practices (eg, yoga, pilates, meditation, psychotherapy, reik, relaxation).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected outcome was to reduce the stress level in the study population after 8 weeks of intervention. The parameter used to evaluate the study outcome was the Perceived Stress Scale (PSS 10) from the finding of a statistically significant change in measurements pre and post intervention.;The results of this study show that the intervention Progressive Muscle Relaxation was effective in reducing the level of stress in the sample studied since it was observed significant decrease in the instrument's score used (PSS10). Randomized controlled trials with larger sample should be done so that these data are confirmed. According to these findings, the intervention Progressive Muscle Relaxation can be considered an important tool in the treatment of stress in people with MS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in the level of depression in the population studied after 8 weeks of intervention. The parameter used to evaluate the study outcome was the Beck Depression Inventory (BDI) from the finding of a statistically significant change in measurements pre and post intervention.;The results of this study show that the intervention Progressive Muscle Relaxation was effective in reducing the level of depression in the sample studied since it was observed significant decrease in the instrument's score used (BDI). Randomized controlled trials with larger sample should be performed so that these data are confirmed. According to these findings, the intervention Progressive Muscle Relaxation can be considered an important tool in the treatment of depressive symptoms in people with MS. ;Improvement of sleep quality in the study population after 8 weeks of intervention. The parameter used to evaluate the outcome of the study was the Pittsburgh Sleep Quality Index (PSQI) from the finding of a statistically significant change in measurements pre and post intervention.;The results of this study show that the intervention Progressive Muscle Relaxation was effective in improving sleep quality in this sample as it was observed significant decrease of the used instrument score (PSQI), indicating that there was an improvement in the quality of sleep in individuals evaluated. Randomized controlled trials with larger sample should be performed so that these data are confirmed. According to these findings, the intervention Progressive Muscle Relaxation can be an affordable and effective practice to improve the quality of sleep in people with MS. | — |
Countries
Brazil
Contacts
Universidade Federal do Espírito Santo;Universidade Federal do Espírito Santo